The DOI matches its Crossref record; 57 of the 60 references it cites were found in a registry or an index.
Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72
Open accessAbstract
Hexanucleotide expansions in C9orf72, which encodes a predicted guanine exchange factor, are the most frequent genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although repeat expansion has been established to generate toxic products, mRNAs encoding the C9ORF72 protein are also reduced in affected individuals. In this study, we tested how C9ORF72 protein levels affected repeat-mediated toxicity. In somatic transgenic mice expressing 66 GGGGCC repeats, inactivation of one or both endogenous C9orf72 alleles provoked or accelerated, respectively, early death. In mice expressing a C9orf72 transgene with 450 repeats that did not encode the C9ORF72 protein, inactivation of one or both endogenous C9orf72 alleles exacerbated cognitive deficits, hippocampal neuron loss, glial activation and accumulation of dipeptide-repeat proteins from translation of repeat-containing RNAs. Reduced C9ORF72 was shown to suppress repeat-mediated elevation in autophagy. These efforts support a disease mechanism in ALS/FTD resulting from reduced C9ORF72, which can lead to autophagy deficits, synergizing with repeat-dependent gain of toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the loss of C9orf72 function and consequent impairment in autophagy may enhance DPR accumulation in C9orf72 mutation carriers, acting synergistically to accentuate neurodegeneration [154,172,173].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [173]
In the citing paper
“On the other hand, loss of endogenous murine C9orf72 results in glial activation, impaired autophagy and toxicity when combined with the C9orf72 expansion mutation [173].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [173]
In the citing paper
“Consistently, it has been recently observed that loss of wild‐type C9orf72 function exacerbates the neurotoxic effects of a C9orf72 mutant allele, bearing hexanucleotide expansions, by repressing autophagy (Zhu et al, 2020).”
From Autophagy in major human diseases (2021) · cites this paper as Zhu et al, 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Decoding ALS: from genes to mechanism
Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,120
Self-citationThe ubiquitin-proteasome proteolytic pathway
Ciechanover, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,804
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,127
Self-citationNon-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B. B., Doty, N. S., Gomes-Pereira, M., Huguet-Lachon, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 928
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
Self-citationRAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
Zu, T., Liu, Y., Báñez-Coronel, M., Reid, T. S., Pletniková, O., Lewis, J. M., Miller, T. M., Harms, M. B., Falchook, A. E., Subramony, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315438110 · Cited by 777
C9orf72-mediated ALS and FTD: multiple pathways to disease
Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715
Cited by
Sorted by citations
Items 101–200 of 220
Sun, S., Shen, Y., Zhang, X., Ding, N., Xu, Z., Zhang, Q., & Li, L. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.016 · Cited by 19
Amalyan, S., Tamboli, S., Lazarevich, I. A., Topolnik, D., Bouman, L. H., & Topolnik, L. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111043 · Cited by 19
Proline/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis
Babu, M., Favretto, F., de Opakua, A. I., Rankovic, M., Becker, S., & Zweckstetter, M. (2021) · Nature Communications · doi:10.1038/s41467-021-23691-y · Cited by 20
Zheng, W., Wang, K., Wu, Y., Ge, Y., Zhang, C., Li, Z., Wang, L., & Chen, S. (2022) · Theranostics · doi:10.7150/thno.76138 · Cited by 18
Schwann Cells in Neuromuscular Disorders: A Spotlight on Amyotrophic Lateral Sclerosis
Moss, K. R., & Saxena, S. (2025) · Cells · doi:10.3390/cells14010047 · Cited by 17
The cGAS-STING-autophagy pathway: Novel perspectives in neurotoxicity induced by manganese exposure
Zhang, X., Liu, J., & Wang, H. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120412 · Cited by 18
Repeated mild traumatic brain injury triggers pathology in asymptomatic C9ORF72 transgenic mice
Kahriman, A., Bouley, J., Tuncali, I., Dogan, E. O., Pereira, M., Luu, T., Bosco, D. A., Jaber, S., Peters, O. M., Brown, R. H., et al. (2023) · Brain · doi:10.1093/brain/awad264 · Cited by 18
Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD
Mayl, K., Shaw, C. E., & Lee, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9060601 · Cited by 18
G-protein coupled receptors in neuroinflammation, neuropharmacology, and therapeutics
Singh, A. P., Shadangi, S., & Rana, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117301 · Cited by 16
Quezada, E. R., Cappelli, C., Díaz, I. D. P., Jury, N., Wightman, N., Brown, R. H., Montecino, M. A., & van Zundert, B. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01039-z · Cited by 17
Myeloid and lymphoid expression of C9orf72 regulates IL-17A signaling in mice
Limone, F., Couto, A., Wang, J.-Y., Zhang, Y., McCourt, B. T., Huang, C., Minkin, A., Jani, M., McNeer, S. K., Keaney, J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg7895 · Cited by 20
Self-citationBeckers, J., & Damme, P. V. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2474796 · Cited by 19
Hyperactivity of Purkinje cell and motor deficits in C9orf72 knockout mice
Liu, Y., Xing, H., Ernst, A. F., Liu, C., Maugee, C., Yokoi, F., Lakshmana, M. K., & Li, Y. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103756 · Cited by 14
Jun, Y., Lee, S., Ban, B.-K., Lee, J., & Gao, F. (2023) · Autophagy · doi:10.1080/15548627.2023.2169309 · Cited by 16
Sonobe, Y., Lee, S., Krishnan, G., Gu, Y., Kwon, D. Y., Gao, F., Roos, R. P., & Kratsios, P. (2023) · eLife · doi:10.7554/elife.83189 · Cited by 15
Luan, T., Li, Q., Huang, Z., Feng, Y., Xu, D., Zhou, Y., Hu, Y., & Wang, T. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01267-2 · Cited by 15
Park, J. H., Chung, C. G., Seo, J., Lee, B., Lee, Y., Kweon, J. H., & Lee, S. B. (2020) · PubMed Central · doi:10.14348/molcells.2020.0130 · Cited by 15
Modelling C9orf72-Related Amyotrophic Lateral Sclerosis in Zebrafish
Fortier, G., Butti, Z., & Patten, S. A. (2020) · Biomedicines · doi:10.3390/biomedicines8100440 · Cited by 15
Fisher, R. M. A., & Torrente, M. P. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1456052 · Cited by 18
The Current Potential Pathogenesis of Amyotrophic Lateral Sclerosis
Jiang, S., & Xu, R. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04269-3 · Cited by 16
Structure of the human C9orf72-SMCR8 complex reveals a multivalent protein interaction architecture
Nörpel, J., Cavadini, S., Schenk, A. D., Graff-Meyer, A., Heß, D., Seebacher, J., Chao, J. A., & Bhaskar, V. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001344 · Cited by 16
Bonham, L. W., Geier, E. G., Sirkis, D. W., Leong, J. K., Ramos, E. M., Wang, Q., Karydas, A., Lee, S. E., Sturm, V. E., Sawyer, R. P., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1448-22.2022 · Cited by 15
Self-citationLoss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation
Bauer, C. S., Webster, C. P., Shaw, A. C., Kok, J. R., Castelli, L. M., Lin, Y.-H., Smith, E. F., Illanes-Álvarez, F., Higginbottom, A., Shaw, P. J., et al. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1061559 · Cited by 15
Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update
Lescouzères, L., & Patten, S. A. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2387791 · Cited by 16
A nop56 Zebrafish Loss-of-Function Model Exhibits a Severe Neurodegenerative Phenotype
Quelle‐Regaldie, A., Folgueira, M., Yáñez, J., Sobrido‐Cameán, D., Alba‐González, A., Barreiro‐Iglesias, A., Sobrido, M. J., & Sanchez, L. E. (2022) · Biomedicines · doi:10.3390/biomedicines10081814 · Cited by 13
Dane, T. L., Gill, A. L., Vieira, F. G., & Denton, K. R. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1134090 · Cited by 15
Houghton, O. H., Mizielinska, S., & Gómez‐Suaga, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.838402 · Cited by 12
Garcia-Guerra, A., Ellerington, R., Gaitzsch, J., Bath, J., Kye, M., Varela, M. A., Battaglia, G., Wood, M. J. A., Manzano, R., Rinaldi, C., et al. (2023) · Nanoscale Advances · doi:10.1039/d2na00846g · Cited by 12
HnRNP Pathologies in Frontotemporal Lobar Degeneration
Jiang, X., Gatt, A. P., & Lashley, T. (2023) · Cells · doi:10.3390/cells12121633 · Cited by 13
Gotoh, S., Mori, K., Fujino, Y., Kawabe, Y., Yamashita, T., Omi, T., Nagata, K., Tagami, S., Nagai, Y., & Ikeda, M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105703 · Cited by 12
Invertebrate genetic models of amyotrophic lateral sclerosis
Zhou, L., & Xu, R. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1328578 · Cited by 12
Sachdev, A., Gill, K., Sckaff, M., Birk, A. M., Arogundade, O. A., Brown, K. A., Chouhan, R. S., Issagholian-Lewin, P. O., Patel, E. M., Watry, H. L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307814121 · Cited by 12
Thumbadoo, K. M., Dieriks, B. V., Murray, H. C., Swanson, M. E. V., Yoo, J. H., Mehrabi, N. F., Turner, C. P., Dragunow, M., Faull, R. L. M., Curtis, M. A., et al. (2024) · Brain · doi:10.1093/brain/awae140 · Cited by 13
Celona, B., Salomonsson, S. E., Wu, H., Dang, B., Kratochvil, H. T., Clelland, C. D., DeGrado, W. F., & Black, B. L. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220020121 · Cited by 14
The progress inC9orf72research: ALS/FTD pathogenesis, functions and structure
Jiang, L., Zhang, T., Lu, K., & Qi, S. (2021) · Small GTPases · doi:10.1080/21541248.2021.1892443 · Cited by 13
Self-citationC9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice
Lopez-Herdoiza, M.-B., Bauché, S., Wilmet, B., Duigou, C. L., Roussel, D., Frah, M., Béal, J., Devely, G., Boluda, S., Frick, P., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1155929 · Cited by 13
Limanaqi, F., Busceti, C. L., Biagioni, F., Cantini, F., Lenzi, P., & Fornai, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114021 · Cited by 11
Cabrera, G. T., Meijboom, K. E., Abdallah, A., Tran, H., Foster, Z. W., Weiss, A., Wightman, N., Stock, R. E., Gendron, T. F., Gruntman, A. M., et al. (2023) · Gene Therapy · doi:10.1038/s41434-023-00418-w · Cited by 11
Self-citationNeuroimmune dysfunction in frontotemporal dementia: Insights from progranulin and C9orf72 deficiency
Hashimoto, K., Jahan, N., Miller, Z., & Huang, E. J. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102599 · Cited by 15
Identification of selective and non-selective C9ORF72 targeting in vivo active siRNAs
Gilbert, J. W., Kennedy, Z., Godinho, B. M. D. C., Summers, A., Weiss, A., Echeverria, D., Bramato, B. M., McHugh, N., Cooper, D., Yamada, K., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102291 · Cited by 8
Yousuf, A., Ahmed, N., & Qurashi, A. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.866021 · Cited by 8
ALS-linked C9orf72–SMCR8 complex is a negative regulator of primary ciliogenesis
Tang, D., Zheng, K., Zhu, J., Jin, X., Bao, H., Jiang, L., Li, H., Wang, Y.-C., Lu, Y., Liu, J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220496120 · Cited by 10
Self-citationProteostasis deregulation as a driver of C9ORF72 pathogenesis
Torres, P., Cabral‐Miranda, F., Gonzalez‐Teuber, V., & Hetz, C. A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15529 · Cited by 9
Drosophila as a model to study autophagy in neurodegenerative diseases and digestive tract
Tzou, F., Wen, J., Yeh, J., Huang, S., Chen, G., & Chan, C. (2021) · IUBMB Life · doi:10.1002/iub.2583 · Cited by 9
Luteijn, M. J., Bhaskar, V., Trojer, D., Schürz, M., Mahboubi, H., Handl, C., Pizzato, N., Pfeifer, M., Dafinca, R., Voshol, H., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf253 · Cited by 8
Lin, L. T., Shenouda, M., McGoldrick, P., Lau, A., & Robertson, J. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02061-5 · Cited by 8
Antisense oligonucleotide therapy in amyotrophic lateral sclerosis
Erdi-Krausz, G., & Shaw, P. J. (2025) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001413 · Cited by 9
López, A., Velasco-Rueda, M., Garcia-Cifuentes, E. R., Zarante, I., & Matallana, D. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.681595 · Cited by 8
Gao, Y., Brothwood, J. L., Saini, H. K., O’Sullivan, G. A., Bento, C. F., McCarthy, J. M., Wallis, N. G., Daniel, E. D., Graham, B. L., & Tams, D. M. (2025) · Glia · doi:10.1002/glia.70084 · Cited by 7
Pasniceanu, I.-S., Atwal, M. S., Souza, C. D. S., Ferraiuolo, L., & Livesey, M. R. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.784833 · Cited by 6
Liu, E. Y., Russ, J., & Lee, E. B. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-2911 · Cited by 7
Ben‐Dor, I., Pacut, C. M., Nevo, Y., Feldman, E. L., & Reubinoff, B. E. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009445 · Cited by 6
Tubulin deacetylase NDST3 modulates lysosomal acidification: Implications in neurological diseases
Tang, Q., Li, X., & Wang, J. (2022) · BioEssays · doi:10.1002/bies.202200110 · Cited by 7
Singh, S., Khan, S., Khan, S., Ansari, O., Malhotra, N., Shukla, S. K., & Narang, J. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00664 · Cited by 7
Verdés, S., Navarro, X., & Bosch, A. (2025) · Human Gene Therapy · doi:10.1177/10430342251372898 · Cited by 8
Between Order and Chaos: Understanding the Mechanism and Pathology of RAN Translation
Reyes, C. J., & Asano, K. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00448 · Cited by 6
Aspects of degradation and translation of the expanded C9orf72 hexanucleotide repeat RNA
Mori, K., Gotoh, S., & Ikeda, M. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15847 · Cited by 6
GC-rich repeat expansions: associated disorders and mechanisms
Schröder, C., Horsthemke, B., & Depienne, C. (2021) · Medizinische Genetik · doi:10.1515/medgen-2021-2099 · Cited by 6
Realizing the gains and losses in C9ORF72 ALS/FTD
Lutz, C. M. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0622-x · Cited by 7
Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD in vitro models
Seidel, M., Rajkumar, S., Steffke, C., Noeth, V., Agarwal, S., Roger, K., Lipecka, J., Ludolph, A. C., Guerrera, I. C., Boeckers, T. M., et al. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100105 · Cited by 5
Liu, X., Zhao, X., He, J., Wang, S., Shen, X., Liu, Q., & Wang, S. (2023) · Molecules · doi:10.3390/molecules28155801 · Cited by 6
Ma, L., Chen, L., Wang, J., Chang, Q., Wang, Y., Zhang, W., Du, Y., Sadan, J., & Chen, J. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac271 · Cited by 4
Translating the ALS Genetic Revolution into Therapies: A Review
Meadows, C., Rau, N. A., Faridi, W., & Ly, C. V. (2024) · Current Treatment Options in Neurology · doi:10.1007/s11940-024-00781-y · Cited by 4
Jiang, Q., Lin, J., Wei, Q., Yang, T., Hou, Y., Zhang, L., Ou, R., Xiao, Y., Wang, S., Zheng, X., et al. (2024) · Journal of Medical Genetics · doi:10.1136/jmg-2024-109909 · Cited by 4
Clinical and electrophysiological findings in C9ORF72 ALS
Sista, S. R., Shelly, S., Oskarsson, B., Rubin, D. I., Martinez‐Thompson, J. M., Parra‐Cantu, C., Staff, N. P., & Laughlin, R. S. (2022) · Muscle & Nerve · doi:10.1002/mus.27665 · Cited by 4
Mori, K., Gotoh, S., Uozumi, R., Miyamoto, T., Akamine, S., Kawabe, Y., Tagami, S., & Ikeda, M. (2023) · JMA Journal · doi:10.31662/jmaj.2022-0160 · Cited by 5
Sckaff, M., Gill, K., Sachdev, A., Birk, A. M., Arogundade, O. A., Watry, H., Keough, K. C., Tsai, Y.-C., Ziegle, J. S., Conklin, B. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.21.492887 · Cited by 4
Masrori, P., Bijnens, B., Davie, K., Poovathingal, S. K., Storm, A., Hersmus, N., Fumagalli, L., Bosch, L. V. D., Fiers, M. W. E. J., Thal, D. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.26.513909 · Cited by 4
Neuroglia in neurodegeneration: Amyotrophic lateral sclerosis and frontotemporal dementia
Marchi, F. D., Spinelli, E. G., & Bendotti, C. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00004-1 · Cited by 4
Basic Concepts and Emergent Disease Mechanisms of Amyotrophic Lateral Sclerosis
Sirozh, O., Sáez-Mas, A., Lafarga, V., & Fernández-Capetillo, Ó. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00266-2 · Cited by 3
RuvBL1/2 reduce toxic dipeptide repeat protein burden in multiple models of C9orf72-ALS/FTD
Webster, C. P., Hall, B., Crossley, O. M., Dauletalina, D., King, M., Lin, Y.-H., Castelli, L. M., Yang, Z.-L., Coldicott, I., Kyrgiou-Balli, E., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402757 · Cited by 2
Is amyotrophic lateral sclerosis less severe in mice than in humans?
Dupuis, L., & Robertson, J. (2025) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001412 · Cited by 2
Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis
Maes, K. J. H., & Briedé, J. J. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150032 · Cited by 4
C9ORF72 Is Pivotal to Maintain a Proper Protein Homeostasis in Mouse Skeletal Muscle
Sironi, F. M., Parlanti, P., Margotta, C., Cassarà, J., Bonetto, V., Bendotti, C., Tortarolo, M., & Cappello, V. (2025) · Cells · doi:10.3390/cells14221765 · Cited by 2
Sironi, F. M., Tortarolo, M., Mazzucchi, S., Camporeale, L., Freschi, M., Arcadipane, E., Giovanetti, G. F., Kurosaki, M., Terao, M., Parlanti, P., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03597-y · Cited by 2
C9orf72 in myeloid cells prevents an inflammatory response to microbial glycogen
McCourt, B. T., Lemr, K., Chakrabarti, S., Woidke, E., Ramaiah, S., Singh, V., Sangwan, N., Brown, J. M., Cominelli, F., Rodriguez‐Palacios, A., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116906 · Cited by 3
The DAXX tax: C9orf72 DNA repeat expansions drive gain- and loss-of-function pathology in c9FTD/ALS
Liu, F., & Rossoll, W. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.028 · Cited by 2
Linking ALS mutations to the disruption of the MHC-II pathway
Zhang, Z., & Sun, S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315240120 · Cited by 2
Jain, S., Das, D., Mukherjee, A., & Roy, I. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05075-1 · Cited by 4
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
(2021) · Frontiers research topics · doi:10.3389/978-2-88966-904-2 · Cited by 3
Thumbadoo, K. M., Dieriks, B. V., Murray, H. C., Swanson, M. E. V., Yoo, J. H., Mehrabi, N. F., Turner, C. P., Dragunow, M., Faull, R. L. M., Curtis, M. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.12.475792 · Cited by 2
Deng, Y.-C., Liu, J.-W., Ting, H.-C., Kuo, T.-C., Chiang, C.-H., Lin, E.-Y., Harn, H.-J., Lin, S., Chang, C., & Chiou, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311573 · Cited by 1
Yeasmin, A., & Torrente, M. P. (2025) · Biology · doi:10.3390/biology14111556 · Cited by 1
Zhang, Y., Xue, Y., Wang, L., Han, Z., Wang, T., Zhang, H., Liu, G., & Xiao, X. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230327 · Cited by 1
Self-citationFlight to insight: maximizing the potential of Drosophila models of C9orf72-FTD
d’Almeida, N. A., & Tipping, M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1434443 · Cited by 1
Unveiling RNA Dysfunction: A Key Player in Neurodegeneration
Pandey, P., Mukherjee, T., Modak, O., & Mutsuddi, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_10 · Cited by 1
Murakami, E., Shibata, T., Tomemori, M., Kawai, G., & Nakatani, K. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d4cp03213f · Cited by 1
Antisense Oligonucleotides for Amyotrophic Lateral Sclerosis
Smith, S., & Miller, T. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89307-0_11 · Cited by 1
Chen‐Plotkin, A. S. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.031 · Cited by 1
Uyan, Ö., Sambare, S., Oomen, M. E., Wightman, N., Schooley, A., Klim, J. R., Belaghzal, H., Aydemir, Ö., Oksuz, B. A., USLU, Z. S. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.22.677835 · Cited by 1
Pinpointing protein as the problem
Arnold, F. J., & Spada, A. R. L. (2026) · Science · doi:10.1126/science.aee6924 · Cited by 1
A repeating theme in amyotrophic lateral sclerosis genetics
Todd, P. K. (2020) · Neurology · doi:10.1212/wnl.0000000000010959
Arogundade, O. A., Jiang, J., & Ravits, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00009-4
Self-citationStructural basis for the ARF GAP activity and specificity of the C9orf72 complexPreprint
Su, M.-Y., Fromm, S. A., Remis, J. P., Toso, D. B., & Hurley, J. H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.13.439632
RNA-Mediated Metabolic Defects in Microsatellite Expansion Diseases
Zhang, N. (2021) · Springer eBooks · doi:10.1007/978-3-030-76571-2_8
Fujino, Y., Ueyama, M., Ishiguro, T., Ozawa, D., Sugiki, T., Ito, H., Murata, A., Ishiguro, A., Gendron, T. F., Mori, K., et al. (2023) · eLife · doi:10.7554/elife.84338.1
Self-citationInhibiting toxicity of ALS-linked dipeptide repeat proteins by polystyrene sulfonate (PSS)Preprint
Bratek‐Skicki, A., Ahmed, J., Lindt, J. V., Jonckheere, K., Peeters, E., Heeren, K., Fakhri, F., Volkov, A., Hendrix, J., Batys, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.19.541518 · Cited by 1
Fujino, Y., Ueyama, M., Ishiguro, T., Ozawa, D., Ito, H., Sugiki, T., Murata, A., Ishiguro, A., Gendron, T. F., Mori, K., et al. (2023) · eLife · doi:10.7554/elife.84338.2
Self-citationLiu, F., Morderer, D., Wren, M. C., Vettleson-Trutza, S. A., Wang, Y., Rabichow, B. E., Salemi, M., Phinney, B. S., Oskarsson, B., Dickson, D. W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19181413
Metadata
- Authors
- Zhu, Q., Jiang, J., Gendron, T. F., McAlonis-Downes, M., Jiang, L., Taylor, A., Diaz Garcia, S., Ghosh Dastidar, S., Rodriguez, M. J., King, P., Zhang, Y., La Spada, A. R., Xu, H., Petrucelli, L., Ravits, J., Da Cruz, S., Lagier-Tourenne, C., & Cleveland, D. W.
- Affiliations
- University of California San Diego (US)
- Emory University (US)
- Mayo Clinic in Florida (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Cleveland, Don W.
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2020-04-13
- Volume
- 23
- Issue
- 5
- Pages
- 615-624
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC7384305
- OpenAlex
- W3015315508
- Cited by
- 220
- References
- 60
- Citations by year
- 2026: 10 · 2025: 26 · 2024: 28 · 2023: 40 · 2022: 35 · 2021: 49 · 2020: 31
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Funders
- Amyotrophic Lateral Sclerosis Association (18-IIA-407, 2313)
- Muscular Dystrophy Association (479769)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (P01-NS099114, P01-NS084974, R01-NS088689, R01-NS27036, R01-NS087227)
- Target ALS
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- C9orf72, hexanucleotide repeat expansion, amyotrophic lateral sclerosis, frontotemporal dementia, dipeptide repeat proteins, autophagy, transgenic mouse model, cognitive impairment, hippocampal neuronal loss, glial activation
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Animals, Disease Models, Animal, Female, Male, Mice, Inbred C57BL, Mice, Transgenic, DNA Repeat Expansion, Mice, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review